Abstract
(Int J Obstet Anesth. 2021;46:102972) Preeclampsia is associated with increased incidence of thrombocytopenia (TCP) and coagulopathy, causing concern about obstetric hemorrhage [postpartum hemorrhage (PPH)] and spinal-epidural hematoma with neuraxial procedures. In the absence of other contraindications, a patient with a platelet count >70×109/L and normal platelet function should be a candidate for a neuraxial procedure. Coagulation testing is not routine in preeclamptic women. Previous data and guidelines on the relationship between coagulation testing and risk of complications from neuraxial procedures are inconsistent. This study aimed to better understand the use of coagulation testing in patients with preeclampsia.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call